GSS vs IPD

ASX Healthcare sector comparison — updated 25 Mar 2026 — Healthcare sector

GSS

GENETICSIG FPO [GSS]

45LOW

IPD

IMPEDIMED FPO [IPD]

45LOW

Score Breakdown

GSS IPD
Technical
73
52
Catalyst
53
50
Sentiment
50
50
Fundamental
66
90
Momentum
24
39
Risk Gate
50
27

Key Metrics

GSS Metric IPD
$18.2MMarket Cap$30.6M
562KAvg Volume (20d)2.6M
N/AShort Interest+0.6%
$0.69052-Week High$0.059
$0.07052-Week Low$0.015
+5.3%Daily Change+0.0%
$0.080Entry Price$0.015
-22.8%ROE-117.9%
-56.5%Profit Margin-171.3%

Active Signals

GSS Signals

RSI drifting toward oversold territory — worth watching
MACD momentum is picking up steam
Stochastic just turned bullish from a low level — early reversal sign
Trading below both moving averages — the trend is working against this one
Smart money may be accumulating — volume is flowing in even though price hasn't moved yet
Volatility is contracting — like a spring being compressed, breakouts often follow
Below the 200-day average — the long-term trend is still working against it
Strong cash runway (12 quarters)

IPD Signals

RSI drifting toward oversold territory — worth watching
Stochastic is deep in oversold territory — bounce conditions forming
Trading below both moving averages — the trend is working against this one
Sitting near support — this level has held before and could attract buyers again
Drifting lower — down 6.3% over the last 5 days
Volatility is contracting — like a spring being compressed, breakouts often follow
Below the 200-day average — the long-term trend is still working against it
Adequate cash runway (5 quarters)

Ask Scout AI to compare GSS and IPD in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
GSS Full Analysis → IPD Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).